Albireo Pharma Future Price Prediction

ALBODelisted Stock  USD 44.15  0.75  1.67%   
Albireo Pharma stock price prediction is an act of determining the future value of Albireo Pharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Albireo Pharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Albireo Pharma and does not consider all of the tangible or intangible factors available from Albireo Pharma's fundamental data. We analyze noise-free headlines and recent hype associated with Albireo Pharma, which may create opportunities for some arbitrage if properly timed.
Check out Trending Equities.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Albireo Pharma based on different types of headlines from major news networks to social media. The Albireo stock price prediction module provides an analysis of price elasticity to changes in media outlook on Albireo Pharma over a specific investment horizon.Using Albireo Pharma hype-based prediction, you can estimate the value of Albireo Pharma from the perspective of Albireo Pharma response to recently generated media hype and the effects of current headlines on its competitors.
Albireo Pharma Price to Sales Ratio is very stable at the moment as compared to the past year. Albireo Pharma reported last year Price to Sales Ratio of 9.93. As of 27th of March 2023, Return on Invested Capital is likely to grow to 22.38, while PPandE Turnover is likely to drop 67.56.
This module is based on analyzing investor sentiment around taking a position in Albireo Pharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Albireo Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Albireo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Albireo Pharma after-hype prediction price

  USD 44.12  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Albireo Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Albireo Pharma in the context of predictive analytics.
LowReal ValueHigh
7 Analysts
LowTarget PriceHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Albireo Pharma. Your research has to be compared to or analyzed against Albireo Pharma's peers to derive any actionable benefits. When done correctly, Albireo Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Albireo Pharma.

Albireo Pharma After-Hype Price Prediction Density Analysis

As far as predicting the price of Albireo Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Albireo Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Albireo Pharma, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Albireo Pharma Estimiated After-Hype Price Volatility

In the context of predicting Albireo Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Albireo Pharma's historical news coverage. Albireo Pharma's after-hype downside and upside margins for the prediction period are 30.44 and 57.80, respectively. We have considered Albireo Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 44.15
After-hype Price
Albireo Pharma is somewhat reliable asset. Analysis and calculation of next after-hype price of Albireo Pharma is based on 3 months time horizon.

Albireo Pharma Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Albireo Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Albireo Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Albireo Pharma, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 2.56  13.68   0.03    1.89  11 Events / Month4 Events / MonthIn about 11 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Albireo Pharma Hype Timeline

Albireo Pharma is presently traded for 44.15. The entity has historical hype elasticity of -0.03 and average elasticity to hype of competition of -1.89. Albireo is forecasted to decline in value after the next headline with the price expected to drop to 44.12. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next newsis expected to be -0.07% whereas the daily expected return is presently at 2.56%. The volatility of related hype on Albireo Pharma is about 1848.65% with expected price after next announcement by competition of 42.26. About 96.0% of the company shares are held by institutions such as insurance companies. The book value of Albireo Pharma was presently reported as 4.84. The company recorded a loss per share of 6.66. Albireo Pharma last dividend was issued on the 4th of November 2016. The entity had 1:30 split on the 4th of November 2016. Given the investment horizon of 90 days the next forecasted press release will be in about 11 days.
Check out Trending Equities.

Albireo Pharma Related Hype Analysis

Having access to credible news sources related to Albireo Pharma's direct competition is more important than ever and may enhance your ability to predict Albireo Pharma's future price movements. Getting to know how Albireo Pharma rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Albireo Pharma may potentially react to the hype associated with one of its peers.

Albireo Pharma Additional Predictive Modules

Most predictive techniques to examine Albireo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Albireo using various technical indicators. When you analyze Albireo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Albireo Pharma Predictive Indicators

The successful prediction of Albireo Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Albireo Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Albireo Pharma based on analysis of Albireo Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Albireo Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Albireo Pharma's related companies.
 2021 2022 2023 (projected)
PPandE Turnover70.8281.4467.56
Long Term Debt to Equity0.0570.05130.0502

Story Coverage note for Albireo Pharma

The number of cover stories for Albireo Pharma depends on current market conditions and Albireo Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Albireo Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Albireo Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Albireo Pharma Short Properties

Albireo Pharma's future price predictability will typically decrease when Albireo Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Albireo Pharma often depends not only on the future outlook of the potential Albireo Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Albireo Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding19.2 M
Cash And Short Term Investments248.1 M
Check out Trending Equities. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Correlations module to find global opportunities by holding instruments from different markets.

Other Consideration for investing in Albireo Stock

If you are still planning to invest in Albireo Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Albireo Pharma's history and understand the potential risks before investing.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Valuation
Check real value of public entities based on technical and fundamental data
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bond Directory
Find actively traded corporate debentures issued by US companies
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope